ReviewJournal of animal science and biotechnology2026
Form-specific selenium supplementation in poultry: linking bioefficacy to mechanisms and precision applications.
Review in Journal of animal science and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Selenium (Se) supplementation in poultry is shifting from deficiency prevention to precision use aimed at measurable improvements in resilience, product quality, and biofortification. Evidence increasingly indicates that, at comparable total dietary Se, bioefficacy varies primarily with chemical form, exposure definition, and retention kinetics. Inorganic salts can correct deficiency and support basal selenoprotein activity, but they provide limited reserve formation. By contrast, selenomethionine (SeMet)-type inputs, including SeMet and OH-SeMet, can build protein-bound Se pools that stabilize Se supply during prolonged stress and are associated with measurable outcomes such as improved feed conversion under heat stress and more predictable egg or tissue enrichment. Biotransformation-derived and engineered systems may provide additional advantages in specific contexts, particularly for mucosal delivery or barrier-related outcomes, but their effects remain strongly product- and formulation-dependent. Mechanistically, source-specific effects reflect differences in Se delivery to selenoprotein synthesis and in the stability of redox and inflammatory control under challenge. A central implication is that matched nominal Se doses do not necessarily represent biologically equivalent exposure, and maximal Se deposition does not necessarily coincide with maximal functional benefit. Thus, deposition targets should be distinguished from functional outcomes such as performance, product quality, and physiological resilience. This review integrates form-specific bioefficacy with mechanistic and application-level evidence and proposes a goal-based precision framework to align Se source and dose with defined production or physiological objectives. Future progress will depend on rigorous source characterization, clearer endpoint alignment, and layered monitoring of exposure, status, and function to enable more predictive and actionable Se use in poultry systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.